GATA2 deficiency and related myeloid neoplasms.

GATA2 deficiency and related myeloid neoplasms.
复制标题

DOI:
10.1053/j.seminhematol.2017.05.002
复制
发表时间:
2017-04
影响因子:
3.6
通讯作者:
Horwitz MS
Horwitz MS
中科院分区:
医学3区
文献类型:
--
作者:
Wlodarski MW;Collin M;Horwitz MS

文献摘要

参考文献

被引文献

相似文献

The GATA2 gene codes for a hematopoietic transcription factor that through its two zinc fingers (ZF) can occupy GATA-DNA motifs in a countless number of genes. It is crucial for the proliferation and maintenance of hematopoietic stem cells. During the past 5 years, germline heterozygous mutations in GATA2 were reported in several hundred patients with various phenotypes ranging from mild cytopenia to severe immunodeficiency involving B cells, natural killer cells, CD4+ cells, monocytes and dendritic cells (MonoMAC/DCML), and myeloid neoplasia. Some patients additionally show syndromic features such as congenital deafness and lymphedema (originally defining the Emberger syndrome) or pulmonary disease and vascular problems. The common clinical denominator in all reported cohorts is the propensity for myeloid neoplasia (myelodysplastic syndrome [MDS], myeloproliferative neoplasms [MPN], chronic myelomonocytic leukemia [CMML], acute myeloid leukemia [AML]) with an overall prevalence of approximately 75% and a median age of onset of roughly 20 years. Three major mutational types are encountered in GATA2-deficient patients: truncating mutations prior to ZF2, missense mutations within ZF2, and noncoding variants in the +9.5kb regulatory region of GATA2. Recurrent somatic lesions comprise monosomy 7 and trisomy 8 karyotypes and mutations in SETBP1 and ASXL1 genes. The high risk for progression to advanced myeloid neoplasia and life-threatening infectious complications guide decision-making towards timely stem cell transplantation.
DOI: 10.1016/j.cell.2014.02.019
发表时间: 2014-04-10
期刊: CELL
影响因子: 64.5
作者:
Groeschel, Stefan;Sanders, Mathijs A.;Delwel, Ruud
通讯作者: Delwel, Ruud
DOI: 10.3324/haematol.2011.054361
发表时间: 2012-06-01
期刊: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
影响因子: --
作者:
Boedoer, Csaba;Renneville, Aline;Owen, Carolyn
通讯作者: Owen, Carolyn
DOI: 10.1182/blood-2011-08-374363
发表时间: 2012-02-02
期刊: BLOOD
影响因子: 20.3
作者:
Kazenwadel, Jan;Secker, Genevieve A.;Harvey, Natasha L.
通讯作者: Harvey, Natasha L.
DOI: 10.1084/jem.20031556
发表时间: 2004-10-04
期刊: The Journal of experimental medicine
影响因子: --
作者:
Ling KW;Ottersbach K;van Hamburg JP;Oziemlak A;Tsai FY;Orkin SH;Ploemacher R;Hendriks RW;Dzierzak E
通讯作者: Dzierzak E
DOI: 10.1182/blood-2013-07-517151
发表时间: 2014-02-06
期刊: BLOOD
影响因子: 20.3
作者:
Dickinson, Rachel E.;Milne, Paul;Collin, Matthew
通讯作者: Collin, Matthew